samedan logo
 
 
spacer
home > pmps > spring 2004 > overt anticounterfeit protection for pharmaceutical drugs
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Overt Anticounterfeit Protection for Pharmaceutical Drugs

Product Counterfeiting is a Major Global Issue that Directly Impacts
Business and Consumers

Companies invest heavily in creating and building brands for a wide variety of products. Well-known brands are an extremely valuable corporate asset and become vulnerable to illegal exploitation by criminals. Unfortunately, the pharmaceutical industry is not immune to this problem and, in many ways, is a highly attractive target for product counterfeiters.

A widely accepted estimate frequently mentioned is that counterfeiting accounts for five to seven per cent of world trade (1). This equated to $400 to $570 billion in 2002, with anticipated future growth of 15-20 per cent each year. Some estimates assess the problem at closer to 10 per cent of world trade. Another way of looking at this is that manufacturers of counterfeit products have grabbed significant market share from brand owners.

The criminals are, in essence, competing against branded product manufacturers, but without the costs of advertising and all the overheads of running a legitimate business. It is very difficult to accurately gauge the size of the problem because of the clandestine nature of the activity and a continued reluctance by many brand owners to address the issue.

Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Andrew Rink, Marketing Manager for Product Security at Flex Products, a JDS Uniphase Company

Andrew Rink has over 10 years' international marketing, sales and technical experience in the brand security market. He has advised a wide variety of multinational corporations and governments around the globe on protecting their branded products and value documents. Andrew earned a Business degree from Skidmore College in New York and is a long-standing member of Mensa. Since 2003, Andrew has had global marketing responsibility for JDS Uniphase light interference authentication products used in brand security.
spacer
Andrew Rink
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

FT Global Pharmaceutical and Biotechnology Conference 2008

2-3 December 2008, The Cumberland, London

FT Global Pharmaceutical and Biotechnology Conference is Europe’s pre-eminent industry event attended by leading executives, government decision makers, investors, analysts and other specialist providers. It provides a unique platform to present new perspectives,’ feel the pulse’ of the industry, and network with peers across the sector.
More info >>

 
News and Press Releases

BASi Opens New Office in Europe

12th November 2008
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement